Survival differences among patients with hepatocellular carcinoma based on the stage of disease and therapy received: pre and post sorafenib era

BACKGROUND: The incidence of hepatocellular carcinoma (HCC) is increasing. Development of newer therapeutic modalities has changed the paradigm of HCC treatment in recent years. So, the aim of our study is to analyze the impact of these treatment modalities into the survival of HCC patients, based o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Gastrointest Oncol
Main Authors: Shah, Chintan, Mramba, Lazarus K., Bishnoi, Rohit, Bejjanki, Harini, Chhatrala, Hardik Satish, Chandana, Sreenivasa R.
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2017
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5674257/
https://ncbi.nlm.nih.gov/pubmed/29184682
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2017.06.16
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados